1. Home
  2. HAE vs ICUI Comparison

HAE vs ICUI Comparison

Compare HAE & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HAE

Haemonetics Corporation

HOLD

Current Price

$109.22

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$152.09

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAE
ICUI
Founded
1971
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.6B
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
HAE
ICUI
Price
$109.22
$152.09
Analyst Decision
Buy
Strong Buy
Analyst Count
9
3
Target Price
$84.13
$169.00
AVG Volume (30 Days)
518.5K
184.9K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
100.62
EPS
0.72
1.96
Revenue
$910,373,000.00
$2,231,262,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.23
$4.46
P/E Ratio
$149.44
$78.02
Revenue Growth
N/A
N/A
52 Week Low
$47.32
$112.50
52 Week High
$109.83
$192.85

Technical Indicators

Market Signals
Indicator
HAE
ICUI
Relative Strength Index (RSI) 72.04 26.54
Support Level $100.53 $146.59
Resistance Level $109.57 $160.22
Average True Range (ATR) 2.69 4.61
MACD -0.28 -2.03
Stochastic Oscillator 87.65 5.18

Price Performance

Historical Comparison
HAE
ICUI

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: